{"version":"1","article":{"id":"eu-breast-cancer-screening-programmes-mammography-capacity-2024","slug":"eu-breast-cancer-screening-programmes-mammography-capacity-2024","language":"en","url":"https://haberpaper.com/en/news/eu-breast-cancer-screening-programmes-mammography-capacity-2024","api_url":"https://haberpaper.com/api/v1/articles/eu-breast-cancer-screening-programmes-mammography-capacity-2024?lang=en","title":"Eurostat: Breast screening rates differ widely across EU countries","summary":"Eurostat’s 2 October snapshot of 2024 programme data puts screening among eligible women aged 50–69 at 82.1% in Denmark and 27.2% in Hungary. Programme coverage is not a measure for all women, and mammography capacity is a separate indicator.","category":"economy","region":"world","topics":[],"published_at":"2026-10-04T13:00:06+03:00","modified_at":"2026-10-04T13:00:06+03:00","publication_basis":"publication-record","event_period":"2024-12","event_period_basis":"event-or-reference-period","sources":[{"name":"Eurostat — Breast cancer screening in the EU: a snapshot","url":"https://ec.europa.eu/eurostat/fr/web/products-eurostat-news/w/edn-20261002-1","publishedAt":"2026-10-02","checkedAt":"2026-10-04"},{"name":"Eurostat dataset hlth_ps_prev — Preventive cancer screenings, programme data","url":"https://ec.europa.eu/eurostat/databrowser/view/hlth_ps_prev/default/table?lang=en","publishedAt":"2026-07-13","checkedAt":"2026-10-04"},{"name":"Eurostat dataset hlth_rs_medim — Devices for medical imaging","url":"https://ec.europa.eu/eurostat/databrowser/view/hlth_rs_medim/default/table?lang=en","publishedAt":"2026-07-13","checkedAt":"2026-10-04"}],"translations":[{"language":"tr","url":"https://haberpaper.com/tr/news/eu-breast-cancer-screening-programmes-mammography-capacity-2024","api_url":"https://haberpaper.com/api/v1/articles/eu-breast-cancer-screening-programmes-mammography-capacity-2024?lang=tr"},{"language":"en","url":"https://haberpaper.com/en/news/eu-breast-cancer-screening-programmes-mammography-capacity-2024","api_url":"https://haberpaper.com/api/v1/articles/eu-breast-cancer-screening-programmes-mammography-capacity-2024?lang=en"},{"language":"ar","url":"https://haberpaper.com/ar/news/eu-breast-cancer-screening-programmes-mammography-capacity-2024","api_url":"https://haberpaper.com/api/v1/articles/eu-breast-cancer-screening-programmes-mammography-capacity-2024?lang=ar"},{"language":"fr","url":"https://haberpaper.com/fr/news/eu-breast-cancer-screening-programmes-mammography-capacity-2024","api_url":"https://haberpaper.com/api/v1/articles/eu-breast-cancer-screening-programmes-mammography-capacity-2024?lang=fr"},{"language":"es","url":"https://haberpaper.com/es/news/eu-breast-cancer-screening-programmes-mammography-capacity-2024","api_url":"https://haberpaper.com/api/v1/articles/eu-breast-cancer-screening-programmes-mammography-capacity-2024?lang=es"}],"data_types":["metrics"],"data":{"version":1,"blocks":[{"id":"eu-screening-and-capacity-2024","type":"metrics","title":{"tr":"Meme kanseri tarama programı ve mamografi cihazı göstergeleri","en":"Breast screening programme and mammography equipment indicators","ar":"مؤشرات برامج الفحص وأجهزة تصوير الثدي","fr":"Indicateurs des programmes de dépistage et des appareils","es":"Indicadores de programas de cribado y equipos"},"description":{"tr":"Ülke bazında yayımlanan program katılım oranları, 2019’dan yüzde puan değişimleri ve mamografi cihazı yoğunluğu. Her gösterge kendi paydasını korur.","en":"Published country programme participation rates, percentage-point changes since 2019, and mammography unit density. Each indicator retains its own denominator.","ar":"معدلات المشاركة الوطنية المنشورة والتغير بالنقاط المئوية منذ 2019 وكثافة أجهزة التصوير. يحتفظ كل مؤشر بمقامه الخاص.","fr":"Taux nationaux publiés, variations en points depuis 2019 et densité des appareils ; chaque indicateur conserve son propre dénominateur.","es":"Tasas nacionales publicadas, cambios en puntos desde 2019 y densidad de equipos; cada indicador conserva su denominador."},"methodology":{"tr":"Tarama oranı, program için uygun 50–69 yaş kadınlardan önceki iki yılda veya ulusal önerilen sıklıkta mamografi çektirenlerin payıdır; İsveç yaş aralığı 40–74’tür. Değişim mutlak yüzde puandır. Cihaz yoğunluğu nüfus başına 100.000 ölçeğinde olup yalnız mamografi için tasarlanmış makineleri sayar. Eksik ülkeler sıfır sayılmaz.","en":"The screening rate is the share of programme-eligible women aged 50–69 who had mammography in the previous two years or at the nationally recommended frequency; Sweden covers ages 40–74. Change is an absolute percentage-point difference. Equipment density counts machines designed exclusively for mammography per 100,000 inhabitants. Missing countries are not zeros.","ar":"معدل الفحص هو حصة النساء المؤهلات للبرنامج بعمر 50–69 عاماً اللواتي خضعن للتصوير خلال السنتين السابقتين أو وفق الوتيرة الوطنية الموصى بها؛ ويغطي البرنامج السويدي أعمار 40–74. التغير فرق مطلق بالنقاط المئوية. كثافة الأجهزة عدد الآلات المخصصة حصراً للتصوير لكل 100 ألف نسمة. البيانات المفقودة ليست صفراً.","fr":"Le taux est la part des femmes admissibles de 50–69 ans ayant passé une mammographie dans les deux années précédentes ou selon la fréquence nationale ; la Suède couvre les 40–74 ans. La variation est une différence absolue en points. La densité compte les appareils exclusivement conçus pour la mammographie pour 100 000 habitants. Une donnée absente n’est pas zéro.","es":"La tasa es la proporción de mujeres elegibles de 50–69 años que se hicieron una mamografía en los dos años anteriores o según la frecuencia nacional; Suecia cubre de 40 a 74 años. El cambio es una diferencia absoluta en puntos porcentuales. La densidad cuenta equipos diseñados exclusivamente para mamografías por 100.000 habitantes. La ausencia de datos no es cero."},"sourceUrls":["https://ec.europa.eu/eurostat/fr/web/products-eurostat-news/w/edn-20261002-1","https://ec.europa.eu/eurostat/databrowser/view/hlth_ps_prev/default/table?lang=en","https://ec.europa.eu/eurostat/databrowser/view/hlth_rs_medim/default/table?lang=en"],"updatedAt":"2026-07-13T09:00:00Z","items":[{"label":{"tr":"Taramaya katılım oranı","en":"Screening programme rate","ar":"معدل المشاركة في برنامج الفحص","fr":"Taux de participation au dépistage","es":"Tasa de participación en el cribado"},"value":82.1,"unit":"percent","period":"2024","basis":"observed","measure":{"id":"eligible-women-screening-rate","unitCode":"percent","geography":"denmark","frequency":"annual","aggregation":"rate","periodRole":"reference-period"}},{"label":{"tr":"Taramaya katılım oranı","en":"Screening programme rate","ar":"معدل المشاركة في برنامج الفحص","fr":"Taux de participation au dépistage","es":"Tasa de participación en el cribado"},"value":82,"unit":"percent","period":"2024","basis":"observed","measure":{"id":"eligible-women-screening-rate","unitCode":"percent","geography":"sweden","frequency":"annual","aggregation":"rate","periodRole":"reference-period"}},{"label":{"tr":"Taramaya katılım oranı","en":"Screening programme rate","ar":"معدل المشاركة في برنامج الفحص","fr":"Taux de participation au dépistage","es":"Tasa de participación en el cribado"},"value":81.6,"unit":"percent","period":"2024","basis":"observed","measure":{"id":"eligible-women-screening-rate","unitCode":"percent","geography":"finland","frequency":"annual","aggregation":"rate","periodRole":"reference-period"}},{"label":{"tr":"Taramaya katılım oranı","en":"Screening programme rate","ar":"معدل المشاركة في برنامج الفحص","fr":"Taux de participation au dépistage","es":"Tasa de participación en el cribado"},"value":77.8,"unit":"percent","period":"2024","basis":"observed","measure":{"id":"eligible-women-screening-rate","unitCode":"percent","geography":"slovenia","frequency":"annual","aggregation":"rate","periodRole":"reference-period"}},{"label":{"tr":"Taramaya katılım oranı","en":"Screening programme rate","ar":"معدل المشاركة في برنامج الفحص","fr":"Taux de participation au dépistage","es":"Tasa de participación en el cribado"},"value":71.2,"unit":"percent","period":"2024","basis":"observed","measure":{"id":"eligible-women-screening-rate","unitCode":"percent","geography":"ireland","frequency":"annual","aggregation":"rate","periodRole":"reference-period"}},{"label":{"tr":"Taramaya katılım oranı","en":"Screening programme rate","ar":"معدل المشاركة في برنامج الفحص","fr":"Taux de participation au dépistage","es":"Tasa de participación en el cribado"},"value":27.2,"unit":"percent","period":"2024","basis":"observed","measure":{"id":"eligible-women-screening-rate","unitCode":"percent","geography":"hungary","frequency":"annual","aggregation":"rate","periodRole":"reference-period"}},{"label":{"tr":"Taramaya katılım oranı","en":"Screening programme rate","ar":"معدل المشاركة في برنامج الفحص","fr":"Taux de participation au dépistage","es":"Tasa de participación en el cribado"},"value":29.2,"unit":"percent","period":"2024","basis":"observed","measure":{"id":"eligible-women-screening-rate","unitCode":"percent","geography":"cyprus","frequency":"annual","aggregation":"rate","periodRole":"reference-period"}},{"label":{"tr":"Taramaya katılım oranı","en":"Screening programme rate","ar":"معدل المشاركة في برنامج الفحص","fr":"Taux de participation au dépistage","es":"Tasa de participación en el cribado"},"value":33.8,"unit":"percent","period":"2024","basis":"observed","measure":{"id":"eligible-women-screening-rate","unitCode":"percent","geography":"poland","frequency":"annual","aggregation":"rate","periodRole":"reference-period"}},{"label":{"tr":"Taramaya katılım oranı","en":"Screening programme rate","ar":"معدل المشاركة في برنامج الفحص","fr":"Taux de participation au dépistage","es":"Tasa de participación en el cribado"},"value":38.2,"unit":"percent","period":"2024","basis":"observed","measure":{"id":"eligible-women-screening-rate","unitCode":"percent","geography":"latvia","frequency":"annual","aggregation":"rate","periodRole":"reference-period"}},{"label":{"tr":"Taramaya katılım oranı","en":"Screening programme rate","ar":"معدل المشاركة في برنامج الفحص","fr":"Taux de participation au dépistage","es":"Tasa de participación en el cribado"},"value":41.3,"unit":"percent","period":"2024","basis":"observed","measure":{"id":"eligible-women-screening-rate","unitCode":"percent","geography":"austria","frequency":"annual","aggregation":"rate","periodRole":"reference-period"}},{"label":{"tr":"2019’dan değişim","en":"Change since 2019","ar":"التغير منذ 2019","fr":"Évolution depuis 2019","es":"Cambio desde 2019"},"value":12.5,"unit":"percentage points","period":"2024","basis":"observed","measure":{"id":"screening-rate-change","unitCode":"percentage-point","geography":"slovakia","frequency":"annual","aggregation":"change","periodRole":"reference-period"},"periodStart":"2019"},{"label":{"tr":"2019’dan değişim","en":"Change since 2019","ar":"التغير منذ 2019","fr":"Évolution depuis 2019","es":"Cambio desde 2019"},"value":10,"unit":"percentage points","period":"2024","basis":"observed","measure":{"id":"screening-rate-change","unitCode":"percentage-point","geography":"croatia","frequency":"annual","aggregation":"change","periodRole":"reference-period"},"periodStart":"2019"},{"label":{"tr":"2019’dan değişim","en":"Change since 2019","ar":"التغير منذ 2019","fr":"Évolution depuis 2019","es":"Cambio desde 2019"},"value":9.9,"unit":"percentage points","period":"2024","basis":"observed","measure":{"id":"screening-rate-change","unitCode":"percentage-point","geography":"estonia","frequency":"annual","aggregation":"change","periodRole":"reference-period"},"periodStart":"2019"},{"label":{"tr":"2019’dan değişim","en":"Change since 2019","ar":"التغير منذ 2019","fr":"Évolution depuis 2019","es":"Cambio desde 2019"},"value":-0.4,"unit":"percentage points","period":"2024","basis":"observed","measure":{"id":"screening-rate-change","unitCode":"percentage-point","geography":"ireland","frequency":"annual","aggregation":"change","periodRole":"reference-period"},"periodStart":"2019"},{"label":{"tr":"2019’dan değişim","en":"Change since 2019","ar":"التغير منذ 2019","fr":"Évolution depuis 2019","es":"Cambio desde 2019"},"value":-21.8,"unit":"percentage points","period":"2024","basis":"observed","measure":{"id":"screening-rate-change","unitCode":"percentage-point","geography":"malta","frequency":"annual","aggregation":"change","periodRole":"reference-period"},"periodStart":"2019"},{"label":{"tr":"2019’dan değişim","en":"Change since 2019","ar":"التغير منذ 2019","fr":"Évolution depuis 2019","es":"Cambio desde 2019"},"value":1.3,"unit":"units per 100000 inhabitants","period":"2024","basis":"observed","measure":{"id":"mammography-unit-density-change","unitCode":"per-100000-inhabitants","geography":"cyprus","frequency":"annual","aggregation":"change","periodRole":"reference-period"},"periodStart":"2019"},{"label":{"tr":"2019’dan değişim","en":"Change since 2019","ar":"التغير منذ 2019","fr":"Évolution depuis 2019","es":"Cambio desde 2019"},"value":-0.8,"unit":"units per 100000 inhabitants","period":"2024","basis":"observed","measure":{"id":"mammography-unit-density-change","unitCode":"per-100000-inhabitants","geography":"sweden","frequency":"annual","aggregation":"change","periodRole":"reference-period"},"periodStart":"2019"},{"label":{"tr":"100.000 kişi başına mamografi cihazı","en":"Mammography units per 100,000 inhabitants","ar":"أجهزة تصوير الثدي لكل 100 ألف نسمة","fr":"Appareils de mammographie pour 100 000 habitants","es":"Mamógrafos por cada 100.000 habitantes"},"value":7.6,"unit":"units per 100000 inhabitants","period":"2024","basis":"observed","measure":{"id":"mammography-units-density","unitCode":"per-100000-inhabitants","geography":"greece","frequency":"annual","aggregation":"rate","periodRole":"reference-period"}},{"label":{"tr":"100.000 kişi başına mamografi cihazı","en":"Mammography units per 100,000 inhabitants","ar":"أجهزة تصوير الثدي لكل 100 ألف نسمة","fr":"Appareils de mammographie pour 100 000 habitants","es":"Mamógrafos por cada 100.000 habitantes"},"value":6.9,"unit":"units per 100000 inhabitants","period":"2024","basis":"observed","measure":{"id":"mammography-units-density","unitCode":"per-100000-inhabitants","geography":"cyprus","frequency":"annual","aggregation":"rate","periodRole":"reference-period"}},{"label":{"tr":"100.000 kişi başına mamografi cihazı","en":"Mammography units per 100,000 inhabitants","ar":"أجهزة تصوير الثدي لكل 100 ألف نسمة","fr":"Appareils de mammographie pour 100 000 habitants","es":"Mamógrafos por cada 100.000 habitantes"},"value":3.7,"unit":"units per 100000 inhabitants","period":"2024","basis":"observed","measure":{"id":"mammography-units-density","unitCode":"per-100000-inhabitants","geography":"italy","frequency":"annual","aggregation":"rate","periodRole":"reference-period"}},{"label":{"tr":"100.000 kişi başına mamografi cihazı","en":"Mammography units per 100,000 inhabitants","ar":"أجهزة تصوير الثدي لكل 100 ألف نسمة","fr":"Appareils de mammographie pour 100 000 habitants","es":"Mamógrafos por cada 100.000 habitantes"},"value":1.1,"unit":"units per 100000 inhabitants","period":"2024","basis":"observed","measure":{"id":"mammography-units-density","unitCode":"per-100000-inhabitants","geography":"poland","frequency":"annual","aggregation":"rate","periodRole":"reference-period"}},{"label":{"tr":"100.000 kişi başına mamografi cihazı","en":"Mammography units per 100,000 inhabitants","ar":"أجهزة تصوير الثدي لكل 100 ألف نسمة","fr":"Appareils de mammographie pour 100 000 habitants","es":"Mamógrafos por cada 100.000 habitantes"},"value":1.1,"unit":"units per 100000 inhabitants","period":"2024","basis":"observed","measure":{"id":"mammography-units-density","unitCode":"per-100000-inhabitants","geography":"czechia","frequency":"annual","aggregation":"rate","periodRole":"reference-period"}},{"label":{"tr":"100.000 kişi başına mamografi cihazı","en":"Mammography units per 100,000 inhabitants","ar":"أجهزة تصوير الثدي لكل 100 ألف نسمة","fr":"Appareils de mammographie pour 100 000 habitants","es":"Mamógrafos por cada 100.000 habitantes"},"value":1.1,"unit":"units per 100000 inhabitants","period":"2024","basis":"observed","measure":{"id":"mammography-units-density","unitCode":"per-100000-inhabitants","geography":"sweden","frequency":"annual","aggregation":"rate","periodRole":"reference-period"}},{"label":{"tr":"100.000 kişi başına mamografi cihazı","en":"Mammography units per 100,000 inhabitants","ar":"أجهزة تصوير الثدي لكل 100 ألف نسمة","fr":"Appareils de mammographie pour 100 000 habitants","es":"Mamógrafos por cada 100.000 habitantes"},"value":1.1,"unit":"units per 100000 inhabitants","period":"2024","basis":"observed","measure":{"id":"mammography-units-density","unitCode":"per-100000-inhabitants","geography":"romania","frequency":"annual","aggregation":"rate","periodRole":"reference-period"}}]}]},"data_compilations":[{"id":"eu-screening-and-capacity-2024","creator":{"@type":"Organization","@id":"https://haberpaper.com/#organization","name":"Haber Paper","url":"https://haberpaper.com/"},"license":{"@type":"CreativeWork","@id":"https://haberpaper.com/en/data-terms/v1#license","name":"Haber Paper Original Data Compilation License 1.0","url":"https://haberpaper.com/en/data-terms/v1"},"rights_scope":"Haber Paper original data arrangement, labels and methodology notes only; underlying source rights and permissions remain separate.","source_license_url":null}],"data_downloads":[{"id":"eu-screening-and-capacity-2024","formats":{"json":"https://haberpaper.com/api/v1/articles/eu-breast-cancer-screening-programmes-mammography-capacity-2024/data/eu-screening-and-capacity-2024?lang=en&format=json","csv":"https://haberpaper.com/api/v1/articles/eu-breast-cancer-screening-programmes-mammography-capacity-2024/data/eu-screening-and-capacity-2024?lang=en&format=csv"}}],"content":{"paragraphs":["Eurostat’s snapshot published on 2 October compares two different parts of health-system capacity: administrative programme participation in breast screening and the number of mammography machines relative to population. For the first indicator, the reference year is 2024. Denmark recorded 82.1% of eligible women in the published age group, Sweden 82.0%, Finland 81.6%, Slovenia 77.8% and Ireland 71.2%. At the lower end of countries with values, Hungary recorded 27.2%, Cyprus 29.2%, Poland 33.8%, Latvia 38.2% and Austria 41.3%. These figures describe programme records; they do not establish why countries differ, nor do they measure an individual woman’s health or outcome.","The denominator matters. Eurostat says the rate is the share of women aged 50 to 69 who had mammography during the previous two years, or according to the screening interval recommended nationally, among women eligible for an organised programme. This is not a population-wide estimate for every woman in that age range. National rules and collection systems vary, and the source notes that some changes may have occurred during the period. Sweden’s programme covers ages 40 to 74, a wider range than the headline comparison. Bulgaria and Romania have no national breast-cancer screening programme and therefore no comparable programme rate; Greece’s rate is also unavailable. In other countries, screening may take place through general practitioners or programme data may not be collectable. Missing observations must not be read as zero participation.","The change since 2019 is reported in percentage points, which is an absolute difference between two percentages, not a relative growth rate. Among countries with available data, nine increased. Slovakia had the largest rise, 12.5 percentage points, followed by Croatia at 10.0 and Estonia at 9.9. Sweden and Finland were unchanged. The other 11 countries recorded declines, ranging from 0.4 percentage points in Ireland to 21.8 in Malta. These comparisons describe the difference between reported endpoints; the release does not provide a full annual series here, so they should not be turned into a year-by-year trajectory or explanation.","A separate indicator concerns machines designed exclusively for mammograms, measured per 100,000 inhabitants. In 2024, Greece reported 7.6 units and Cyprus 6.9, followed by Italy at 3.7. Poland, Czechia, Sweden and Romania were at the low end, each with 1.1. Compared with 2019, density rose in ten countries, most in Cyprus by 1.3 units per 100,000 inhabitants; it fell in four, including Sweden by 0.8 and Malta by 0.7, while six were unchanged. Equipment density uses the whole population as denominator, unlike programme participation, whose denominator is eligible women. It is not a direct measure of appointment availability, geographic access, machine utilisation, waiting time or quality of care. Data for Germany, Ireland, France, Hungary, the Netherlands and Portugal are unavailable for both comparison years.","The figures come from Eurostat datasets hlth_ps_prev and hlth_rs_medim, which the statistical office last updated on 13 July 2026; the news snapshot was released on 2 October. The first dataset contains programme-based preventive screening rates, while the second records medical imaging devices. Their differing concepts and gaps limit cross-country interpretation. Neither indicator alone establishes screening effectiveness, cancer incidence, mortality, or the reason behind a trend. The data are useful for describing reported programme reach and equipment density, with those boundaries visible. They are not personal medical guidance, and readers should not infer an individual screening recommendation from a country comparison."],"key_points":[],"sections":[]},"text":"Eurostat’s 2 October snapshot of 2024 programme data puts screening among eligible women aged 50–69 at 82.1% in Denmark and 27.2% in Hungary. Programme coverage is not a measure for all women, and mammography capacity is a separate indicator.\n\nEurostat’s snapshot published on 2 October compares two different parts of health-system capacity: administrative programme participation in breast screening and the number of mammography machines relative to population. For the first indicator, the reference year is 2024. Denmark recorded 82.1% of eligible women in the published age group, Sweden 82.0%, Finland 81.6%, Slovenia 77.8% and Ireland 71.2%. At the lower end of countries with values, Hungary recorded 27.2%, Cyprus 29.2%, Poland 33.8%, Latvia 38.2% and Austria 41.3%. These figures describe programme records; they do not establish why countries differ, nor do they measure an individual woman’s health or outcome.\n\nThe denominator matters. Eurostat says the rate is the share of women aged 50 to 69 who had mammography during the previous two years, or according to the screening interval recommended nationally, among women eligible for an organised programme. This is not a population-wide estimate for every woman in that age range. National rules and collection systems vary, and the source notes that some changes may have occurred during the period. Sweden’s programme covers ages 40 to 74, a wider range than the headline comparison. Bulgaria and Romania have no national breast-cancer screening programme and therefore no comparable programme rate; Greece’s rate is also unavailable. In other countries, screening may take place through general practitioners or programme data may not be collectable. Missing observations must not be read as zero participation.\n\nThe change since 2019 is reported in percentage points, which is an absolute difference between two percentages, not a relative growth rate. Among countries with available data, nine increased. Slovakia had the largest rise, 12.5 percentage points, followed by Croatia at 10.0 and Estonia at 9.9. Sweden and Finland were unchanged. The other 11 countries recorded declines, ranging from 0.4 percentage points in Ireland to 21.8 in Malta. These comparisons describe the difference between reported endpoints; the release does not provide a full annual series here, so they should not be turned into a year-by-year trajectory or explanation.\n\nA separate indicator concerns machines designed exclusively for mammograms, measured per 100,000 inhabitants. In 2024, Greece reported 7.6 units and Cyprus 6.9, followed by Italy at 3.7. Poland, Czechia, Sweden and Romania were at the low end, each with 1.1. Compared with 2019, density rose in ten countries, most in Cyprus by 1.3 units per 100,000 inhabitants; it fell in four, including Sweden by 0.8 and Malta by 0.7, while six were unchanged. Equipment density uses the whole population as denominator, unlike programme participation, whose denominator is eligible women. It is not a direct measure of appointment availability, geographic access, machine utilisation, waiting time or quality of care. Data for Germany, Ireland, France, Hungary, the Netherlands and Portugal are unavailable for both comparison years.\n\nThe figures come from Eurostat datasets hlth_ps_prev and hlth_rs_medim, which the statistical office last updated on 13 July 2026; the news snapshot was released on 2 October. The first dataset contains programme-based preventive screening rates, while the second records medical imaging devices. Their differing concepts and gaps limit cross-country interpretation. Neither indicator alone establishes screening effectiveness, cancer incidence, mortality, or the reason behind a trend. The data are useful for describing reported programme reach and equipment density, with those boundaries visible. They are not personal medical guidance, and readers should not infer an individual screening recommendation from a country comparison.","corrections":[],"editorial_illustration":{"kind":"symbolic-editorial-illustration","documentary":false,"scope":"section","asset_id":"economy","url":"https://haberpaper.com/assets/illustrations/economy-1536.webp","width":1536,"height":1024,"alt":"Symbolic trading harbour with a cargo ship, containers and a bridge.","language":"en"},"section_illustration":{"kind":"symbolic-editorial-illustration","documentary":false,"scope":"section","asset_id":"economy","url":"https://haberpaper.com/assets/illustrations/economy-1536.webp","width":1536,"height":1024,"alt":"Symbolic trading harbour with a cargo ship, containers and a bridge.","language":"en"}}}